Amelio Biomedical CO., LTD.
Update:2026/11/10
Industries
Main Industry
Agriculture and Farming
Main Product/Service
Amelio-Chela Series
Amino-Chela Amino MN6
Amino-Chela Amino Ca & Mg
Vit-Boron
Foison
Root Bang
Amino-Chela
Amino-Chela (General/unspecified)
Molecular Awakening
Superior Calcium
Amino-Chela Amino MN6
Amino-Chela Amino Ca & Mg
Vit-Boron
Foison
Root Bang
Amino-Chela
Amino-Chela (General/unspecified)
Molecular Awakening
Superior Calcium
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83051573
Status
Active
Number of Employees
0
Total Paid-in
Capital
22,717,500 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Amelio Biomedical develops innovative hemostatic powder using Metal-Amino Click Synthesis technology. Our biocompatible solution rapidly stops massive bleeding, reducing mortality in trauma, battlefield, and emergency care, with advantages of speed, safety, and scalable production.
The content above was translated by Ai